Amalgamated Bank Athira Pharma, Inc. Transaction History

Amalgamated Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$2.26 - $4.22 $1,778 - $3,321	-787 Reduced 18.6%	3,444 $9,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $909 - $4,458	332 Added 8.52%	4,231 $13,000
Q1 2022 Jun 30, 2022	BUY	$8.96 - $13.51 $34,935 - $52,675	3,899 New	3,899 $53,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.